Author

Vivek Pattan

Observed name: Pattan, Vivek

Institution: NHS Forth Valley

Observed institutions: National Health Service Scotland, NHS Greater Glasgow and Clyde, Stobhill Hospital, Heriot-Watt University, NHS Forth Valley

ORCID: 0000-0002-9991-9695

Observed ORCID: 0000-0002-9991-9695

OpenAlex ID: A5007971870

Antipsychotic treatment of very late-onset schizophrenia-like psychosis (ATLAS): a randomised, controlled, double-blind trial

2018 · Robert Howard, Elizabeth Cort, et al. · The Lancet Psychiatry · 67

Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial

2021 · Patrick Gavin Kehoe, Nicholas Turner, et al. · The Lancet Neurology · 62

Medial temporal lobe function during emotional memory in early Alzheimer’s disease, mild cognitive impairment and healthy ageing: an fMRI study

2013 · Mario A Parra, Vivek Pattan, et al. · BMC Psychiatry · 58

The striatum, the hippocampus, and short-term memory binding: Volumetric analysis of the subcortical grey matter's role in mild cognitive impairment

2019 · Maria C. Valdés Hernández, Rupert Clark, et al. · NeuroImage Clinical · 44

Memory markers in the continuum of the Alzheimer’s clinical syndrome

2022 · Mario A. Parra, Clara Calia, et al. · Alzheimer s Research & Therapy · 39

Comparison of Electroconvulsive Therapy Practice Between London and Bengaluru

2011 · Savithasri V. Eranti, Jagadisha Thirthalli, et al. · Journal of Ect · 13

Amisulpride for very late-onset schizophrenia-like psychosis: the ATLAS three-arm RCT

2018 · Robert Howard, Elizabeth Cort, et al. · Health Technology Assessment · 12

Delivering disease modifying treatments in Alzheimer's disease—An old age psychiatry UK perspective

2023 · Robert Barber, Chineze Ivenso, et al. · International Journal of Geriatric Psychiatry · 3

Development of the Clinical Insight Questionnaire: A Novel Clinical Tool for the Assessment of Insight Into Cognitive Symptoms and Everyday Functioning in People With Neurodegeneration

2025 · Catherine Pennington, Harriet Ball, et al. · International Journal of Geriatric Psychiatry · 2

P2‐485: Toward Harmonisation of Neuropsychological Assessment of Alzheimer's Disease in Europe: Evidence From Novel Cognitive Makers

2018 · Mario Alfredo Parra, Sara Fernández Guinea, et al. · Alzheimer s & Dementia · 1

[p1–491]: Do Semantic Clustering Deficits Underpin Long‐term Memory Binding Impairments in Prodromal Ad?

2017 · Clara Calia, Ellen V. Backhouse, et al. · Alzheimer s & Dementia · 1

[f3–05–02]: a Transcultural Cognitive Marker of Alzheimer's Disease

2017 · Mario Alfredo Parra, Monica Sanches Yassuda, et al. · Alzheimer s & Dementia · 1

A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia

2026 · Shannon Diggin, Laura Rueda-Delgado, et al. · Frontiers in Digital Health

Diagnosis of Alzheimer's disease before dementia: A study of UK psychiatrists

2021 · Madeleine Walpert, Susan Mitchell, et al. · Alzheimer s & Dementia

Works count: 17

Citation count: 303

H-index: 7

I10-index: 7